000 01359 a2200397 4500
005 20250513131420.0
264 0 _c19971204
008 199712s 0 0 eng d
022 _a0007-0920
024 7 _a10.1038/bjc.1997.556
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMarth, C
245 0 0 _aCisplatin resistance is associated with reduced interferon-gamma-sensitivity and increased HER-2 expression in cultured ovarian carcinoma cells.
_h[electronic resource]
260 _bBritish journal of cancer
_c1997
300 _a1328-32 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAntineoplastic Agents
_xpharmacology
650 0 4 _aCisplatin
_xpharmacology
650 0 4 _aDrug Resistance, Neoplasm
650 0 4 _aFemale
650 0 4 _aGenes, erbB-2
650 0 4 _aHLA-DR Antigens
_xanalysis
650 0 4 _aHumans
650 0 4 _aInterferon-gamma
_xpharmacology
650 0 4 _aOvarian Neoplasms
_xdrug therapy
650 0 4 _aTumor Cells, Cultured
700 1 _aWidschwendter, M
700 1 _aKaern, J
700 1 _aJørgensen, N P
700 1 _aWindbichler, G
700 1 _aZeimet, A G
700 1 _aTropé, C
700 1 _aDaxenbichler, G
773 0 _tBritish journal of cancer
_gvol. 76
_gno. 10
_gp. 1328-32
856 4 0 _uhttps://doi.org/10.1038/bjc.1997.556
_zAvailable from publisher's website
999 _c9344254
_d9344254